Latest / Let's Talk Risk! Podcast
LTR 135: Allison Komiyama on Rethinking Benefit-Risk in MedTech
Summary
“We talk about risk all the time, but we forget to talk about the benefit. FDA’s job is to protect and promote public health, and benefit–risk is how those two missions meet.”
In this episode of the Let's Talk Risk Podcast, host Naveen Agarwal sits down with Dr. Allison Komiyama, neuroscientist, former FDA reviewer, regulatory strategist, and founder of Bluestocking Health. Known for her ability to make complex FDA topics understandable and fun, Allison brings fresh clarity to one of the most misunderstood areas in risk management: benefit–risk evaluation.
Together, they explore why…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.